KR
Kent L. Rossman

Elite Scholar

81
Works
11,149
Citations
39
H-Index
Search Authors
Author Statistics
External Links
OpenAlex Profile ORCID Profile

Kent L. Rossman

Also known as: K L Rossman, K. Rossman, K.L. Rossman, Kent L Rossman, Kent L. Rossman

81

Total Works

11,149

Citations

39

H-Index

47

i10-Index

Citation & Works Trend by Year
26 years active
Top Research Topics
Protein Kinase Regulation and GTPase Signaling (74) Cellular transport and secretion (35) Protein Tyrosine Phosphatases (29) Melanoma and MAPK Pathways (17) Receptor Mechanisms and Signaling (14)
Recent Publications
15 shown
Year Publication Title Citations Action
2026 Supplementary Table 3 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Table 1 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Figure 4 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Data from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 1
2026 Supplementary Table 5 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Figure 2 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Table 2 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Table 4 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Figure 1 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Figure 5 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Figure 6 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Supplementary Figure 3 from Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer 0
2026 Activity of direct KRAS(G12C) inhibitors in preclinical models of pediatric cancer. UNC Libraries 0
2026 Aging, Dauer, and Stature Phenotypes Are Conferred by Structure‐Directed Missense Mutations in the Endogenous AGE ‐1/Phosphatidylinositol 3‐Kinase Catalytic Subunit Aging Cell 0
2025 Activity of Direct KRAS(G12C) Inhibitors in Preclinical Models of Pediatric Cancer Molecular Cancer Therapeutics 3

Data source: OpenAlex API